Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists

5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists

US Patent 6369076 · Granted Apr 9, 2002

Estimated economic value: $96,283,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of the menin-MLL interaction2025
Inhibitors of the menin-MLL interaction2023
Dihydropyrrolopyridine inhibitors of ROR-gamma2022
Inhibitors of the menin-MLL interaction2022
Modulators of ROR-gamma2021
Dihydropyrrolopyridine inhibitors of ROR-gamma2021
Inhibitors of the menin-MLL interaction2021
Substituted benzoimidazoles as modulators of ROR-γ2020
Benzimidazole derivatives as modulators of ROR-gamma2020
Dihydropyrrolopyridine inhibitors of ROR-gamma2020
Inhibitors of the menin-MLL interaction2020
Purine derivatives as CD73 inhibitors for the treatment of cancer2020